重组人PD-L2/B7-DC蛋白
产品名称: 重组人PD-L2/B7-DC蛋白
英文名称: Recombinant Human PD-L2/B7-DC Protein
产品编号: GMP-TL728
产品价格:
产品产地: 中国
品牌商标: 同立海源生物
更新时间: 2023-08-21T17:06:39
使用范围: null
规格 | 价格 |
200μg | 3500.0 |
- 联系人 : 崔女士
- 地址 : 北京市大兴区中关村科技园区大兴生物医药产业基地华佗路50号院13号楼
- 邮编 : 100085
- 所在区域 : 北京
- 电话 : 186****3653 点击查看
- 传真 : 点击查看
- 邮箱 : cuilimei@seafrom.cn
重组人PD-L2蛋白(Recombinant Human PD-L2 Protein),GMP级
产品货号:GMP-TL728
产品描述(Description)
Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.
分子别名(Synonym)
PDL2、Butyrophilin B7-DC、CD273、PDCD1 ligand 2、PDCD1L2、PDCD1LG2
表达宿主(Expression host)
HEK293细胞
来源(Source)
Human
纯度(Purity)
≥95%采用SDS-PAGE凝胶和高效液相色谱分析
内毒素(Endotoxin)
<0.1EU/ug
蛋白序列(Protein Sequence)
DNA序列编码人PD-L2(NCBI Reference Sequence:NP_079515.2)表达带有His标签在C末端
分子量(Molecular Weight)
重组人PD-L2蛋白 包含201个氨基酸,预测理论分子量为24kD
生物活性(Biological Activity)
固定人(His 标签)10ug/mL( 100 ul/孔)能够结合人 PD-1(Fc 标签)的线性范围是 0.01-1ug/mL
稳定性(Stability)
冻干的样本的可以在4℃保存24个月,溶解后的液体可以于-20℃保存6-12个月,并且避免反复冻融
组成(Component)
含有6%甘露醇的无菌PBS(PH 7.4)的冻干粉
参考文献
1、PD-L2 regulates B-1 cell antibody production against phosphorylcholine through an IL-5–dependent mechanism Jerome T. McKay, Marcela A. Haro, Christina A. Daly, Rama D. Yammani, Bing Pang, W. Edward Swords, Karen M. Haas J Immunol. Author manuscript; available in PMC 2018 Sep 15. Published in final edited form as: J Immunol. 2017 Sep 15; 199(6): 2020–2029. Published online 2017 Aug 2. doi: 10.4049/jimmunol.1700555
2、PD-L2 expression in colorectal cancer: Independent prognostic effect and targetability by deglycosylation Huanbin Wang, Han Yao, Chushu Li, Lunxi Liang, Yao Zhang, Hubing Shi, Chongzhi Zhou, Yingxuan Chen, Jing-Yuan Fang, Jie Xu Oncoimmunology. 2017; 6(7): e1327494. Published online 2017 May 16. doi: 10.1080/2162402X.2017.1327494
注意:For research and manufacturing use.